Cook Group Incorporated Signs Three-Year Supply Contract With MedAssets HSCA
August 19, 2003
Bloomington, Ind. – Cook Group Incorporated has signed a three-year contract to supply medical products for diagnostic and interventional radiology, gastroenterological and urological procedures to the members of MedAssets HSCA.
“We are delighted to be part of MedAssets HSCA’s contract portfolio,” said Mike Hughes, director, corporate accounts, Cook Group Incorporated. “MedAssets HSCA’s business plan focuses on customized healthcare solutions for their membership. This ‘customer first’ approach fits our company’s philosophy very well and no doubt will have a positive impact on MedAssets HSCA members and ultimately their patients.”
The contract, which is in effect from July 1, 2003 through June 30, 2006, also allows Cook to offer additional product lines from its other medical divisions to MedAssets HSCA members in the future, Hughes explained. He described the contract as a tiered agreement designed to provide flexibility to MedAssets HSCA members.
MedAssets HSCA, headquartered in St. Louis, Missouri, is the third largest group purchasing organization in the country, serving more than 16,000 healthcare providers nationwide with purchasing power approaching $7 billion in gross throughput. It is MedAssets HSCA’s mission to be the market-leading, customer-oriented supply chain and contract services company, focused on maximizing the financial performance of healthcare institutions. For more information about MedAssets HSCA, or its parent company MedAssets Inc., visit www.medassets.com.
With international headquarters in Bloomington, Ind., privately held COOK® (www.cookgroup.com) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for stents and stent-grafts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials, vena cava filters, implanted cardiac lead extraction equipment and other minimally invasive medical devices.